Back to results
US 6,689,569 B2Granted
Saliva test for detection of food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and humoral immunodeficiencies
AssigneeImmunosciences Lab, Inc.
InventorAristo Vojdani
Life of this patent
Estimating the term…
Abstract
A method for determining a cause for digestive and immune disorders is disclosed. The method determines the levels of antibodies against normal intestinal microflora and food antigens. It then compares the results to normal levels to determine the cause. The test can be used to diagnose food allergy or intolerance, microflora imbalance, gut barrier dysfunction, bacterial translocation, immunodeficiencies, candidiasis and autoimmunities.
Claims18
A method for determining the presence of digestive disorders in a patient, comprising:
- (a) determining a level of antibodies against a dietary antigen in a first sample of a mucosal secretion from said patient;
- (b) determining a level of antibodies against a microorganism found in normal intestinal microflora in a second sample of a mucosal secretion from said patient, wherein first and second samples are the same or different,
- (c) comparing the levels determined in steps (a) and (b) with normal levels of said antibodies, wherein
- (i) higher than normal levels of intestinal micro flora antibodies and normal levels of dietary antigen antibodies indicate an intestinal micro flora imbalance,
- (ii) higher than normal levels of dietary antigen antibodies and normal levels of intestinal microflora antibodies indicate a food allergy or food intolerance,
- (iii) higher than normal levels of both dietary antigen antibodies and intestinal microflora antibodies indicate a gut barrier dysfunction, and
- (iv) lower than normal levels of dietary antigen antibodies and microflora antibodies indicate a humoral immunodeficiency.
4 more elements
A method for determining the presence of digestive disorders in a patient, comprising:
- (a) determining a level of secretory IgA in a mucosal secretion sample from said patient;
- (b) comparing the level determined in step (a) with normal levels of said antibodies, wherein
- (i) lower than normal levels of secretory IgA indicates mucosal immunodeficiency and lack of immune reaction to antigens;
- and
- (ii) higher than normal levels of secretory IgA indicates an exposure of mucosal cells to significant levels of antigens.
2 more elements
Dependencies are inferred from the claim text.